Shares of Dolphin Entertainment, Inc. (NASDAQ:DLPN – Get Free Report) were down 0.8% during trading on Monday . The company traded as low as $1.14 and last traded at $1.17. Approximately 33,312 shares changed hands during trading, a decline of 3% from the average daily volume of 34,503 shares. The stock had previously closed at $1.18.
Dolphin Entertainment Stock Down 0.8 %
The company has a debt-to-equity ratio of 0.57, a current ratio of 0.91 and a quick ratio of 0.91. The business’s 50 day simple moving average is $1.33 and its 200 day simple moving average is $1.73. The company has a market capitalization of $13.00 million, a PE ratio of -0.64 and a beta of 1.95.
Dolphin Entertainment (NASDAQ:DLPN – Get Free Report) last issued its earnings results on Wednesday, August 14th. The company reported ($0.16) EPS for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.02. Dolphin Entertainment had a negative net margin of 31.53% and a negative return on equity of 73.80%. The company had revenue of $11.45 million for the quarter.
Dolphin Entertainment Company Profile
Dolphin Entertainment, Inc, together with its subsidiaries, operates as an independent entertainment marketing and production company in the United States. The company operates in two segments, Entertainment Publicity, and Marketing and Content Production. The Entertainment Publicity and Marketing segment provides diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic communications, strategic marketing consulting, social media and influencer marketing, digital marketing, creative branding, talent publicity, and entertainment marketing services, as well as produces promotional video content.
See Also
- Five stocks we like better than Dolphin Entertainment
- What Investors Need to Know About Upcoming IPOs
- Intel: Is Now the Time to Be Brave?
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Using the MarketBeat Dividend Tax Calculator
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Dolphin Entertainment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolphin Entertainment and related companies with MarketBeat.com's FREE daily email newsletter.